<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:  A Cryo-EM Automation and Intelligence Platform for Drug Discovery</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>02/01/2022</AwardEffectiveDate>
<AwardExpirationDate>01/31/2024</AwardExpirationDate>
<AwardTotalIntnAmount>999956.00</AwardTotalIntnAmount>
<AwardAmount>999956</AwardAmount>
<AwardInstrument>
<Value>Cooperative Agreement</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Alastair Monk</SignBlockName>
<PO_EMAI>amonk@nsf.gov</PO_EMAI>
<PO_PHON>7032924392</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase  II project is to improve disease research and drug discovery. Cryogenic Electron Microscopy (cryo-EM) is one of the most impactful and vital tools of biological structure analysis today.  The proposed project improves the current methods to achieve better accuracy and productivity, with faster user training.&lt;br/&gt;&lt;br/&gt;The proposed project improves imaging by cryo-EM. The images currently generated by cryo-EM are highly noisy and thus requires extensive processing to build recognizable structures (proteins and others). Single-particle cryo-EM is a method that produces images of individual particles and can potentially analyze biological structures at the single-molecule level.  This project uses Artificial Intelligence/Machine Learning (AI/ML) techniques to mitigate the issues.  AI/ML algorithms can automate the workflow, facilitating quality data and the development of 3D models.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>01/21/2022</MinAmdLetterDate>
<MaxAmdLetterDate>01/21/2022</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>CoopAgrmnt</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2135832</AwardID>
<Investigator>
<FirstName>Narasimha</FirstName>
<LastName>Kumar</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Narasimha Kumar</PI_FULL_NAME>
<EmailAddress>kumar@healthtechnologyinnovations.com</EmailAddress>
<PI_PHON>5035399528</PI_PHON>
<NSF_ID>000803009</NSF_ID>
<StartDate>01/21/2022</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Health Technology Innovations, Inc.</Name>
<CityName>Portland</CityName>
<ZipCode>972393098</ZipCode>
<PhoneNumber>5037999552</PhoneNumber>
<StreetAddress>4640 SW Macadam Ave</StreetAddress>
<StreetAddress2><![CDATA[Suite 200D]]></StreetAddress2>
<CountryName>United States</CountryName>
<StateName>Oregon</StateName>
<StateCode>OR</StateCode>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>OR03</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>080613233</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>HEALTH TECHNOLOGY INNOVATIONS, INC.</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Health Technology Innovations, LLC.]]></Name>
<CityName>Portland</CityName>
<StateCode>OR</StateCode>
<ZipCode>972394232</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Oregon</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>OR03</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>066E</Code>
<Text>INSTRUMENTATION &amp; DIAGNOSTICS</Text>
</ProgramReference>
<Appropriation>
<Code/>
<Name/>
<APP_SYMB_ID/>
</Appropriation>
<Fund>
<Code>01002223DB</Code>
<Name><![CDATA[NSF RESEARCH & RELATED ACTIVIT]]></Name>
<FUND_SYMB_ID>040100</FUND_SYMB_ID>
</Fund>
<FUND_OBLG>2022~999956</FUND_OBLG>
</Award>
</rootTag>
